BNET Industries
- Public
Dow Jones Description
In January 2006 the company was acquired by Teva Pharmaceutical Industries Ltd of Jerusalem, Israel.
President
Neil W. FlanzraichContact Information
Peer Companies
NAICS Code : 541710
Recent Events
-
Heavy hitters invest $31M in Opko
News & Analysis
Filter by
ivax corp. - All News and Analysis
United States Department of Justice - the J&J connection
BNET
- 2009-11-04
WASHINGTON — The nation's largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will pay $98 million, and drug manufacturer, IVAX Pharmaceuticals of Weston, Florida, will pay $14 million to resolve allegations that Omnicare engaged in kickback schemes with several parties, including IVAX, the Justice Department...
Omnicare settles drug kickbacks probe
BNET
- 2009-11-04
Another day, another drug-marketing settlement. Omnicare, which provides pharmacy services to nursing homes, agreed to pay $98 million to settle allegations that it accepted and asked for kickbacks, the U.S. Justice Department announced. And Teva Pharmaceutical Industries subsidiary IVAX will pay $14 million on claims that it forked over $8...
Depomed Settles Patent Litigation Against IVAX
- 2008-04-07
Depomed to Receive $10 Million in Settlement and Royalties
IVAX Diagnostics Announces Resignation of President and Chief Executive Officer
- 2008-01-03
MIAMI -- IVAX Diagnostics, Inc. (AMEX:IVD) announced today that, after 27 years of distinguished service on behalf the Company and its subsidiaries, Giorgio D'Urso is resigning as President and Chief Executive Officer of the Company and as a member of the Board of Directors of the Company, effective January 10,...
Court Grants Depomed's Motion for Summary Judgment of Patent Infringement Against IVAX
- 2007-12-13
Court Rejects All Summary Judgment Motions From IVAX
IVAX Diagnostics Reports Third Quarter Results
- 2007-11-14
MIAMI -- IVAX Diagnostics, Inc. (AMEX:IVD) reported net revenues for the third quarter of 2007 of $4,972,000, a 2.5% increase over net revenues of $4,852,000 for the same period of 2006. IVAX Diagnostics reported a net loss of $7,841,000 for the third quarter of 2007 compared to a net loss...
IVAX Diagnostics Appoints Kevin D. Clark Chief Operating Officer
- 2007-09-20
MIAMI -- IVAX Diagnostics, Inc. (AMEX:IVD) announced today that, effective September 17, 2007, Kevin D. Clark has been appointed Chief Operating Officer of IVAX Diagnostics. In addition to serving as Chief Operating Officer of IVAX Diagnostics, Mr. Clark will continue to serve as Chief Operating Officer of ImmunoVision, Inc., IVAX...
IVAX Diagnostics Reports Second Quarter Results
- 2007-08-10
Provides Update on the Status of the Development of the PARSEC[R] System
Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007.
- 2007-07-02
M2 PRESSWIRE-2 July 2007-Research and Markets: Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007C1994-2007 M2 COMMUNICATIONS LTD RDATE:04072007 Dublin - Research and Markets ...
Research and Markets: Teva is The Clear Market Leader since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs in the UK 2007
- 2007-07-02
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c61363) has announced the addition of Espicom Business Intelligence report Opportunities and Challenges for Generic Drugs in the UK 2007 to their offering.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Neil W. Flanzraich | President |
| Jimmy Wang | CIO & Vice President |
| Nicholas Bodor | Chief Scientific Officer |
| Thomas E. Beier | CFO & Senior Vice President, Finance |
| Thomas E. McClary | Chief Accounting Officer |
| Rafick Henein | Senior Vice President |
| Steven D. Rubin | General Counsel, Senior Vice President & Secretary |
| Edmund Fry | Vice President, Compliance |
| J. Michael Lopez | Vice President, HR |
| Michael M. Lopez | Vice President, HR |
| Rao Uppaluri | Vice President, Strategic Planning |
| Roberto Prego | Vice President, Latin America |
| Stephen Sheriff | Vice President, Taxation & Tax Counsel |
| David Malina | Director, Investor Relations & Corp Communications |
| Hans Berner Soto | Director, Operations, Latin America |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | President | Current |
| Equity One, Inc. | Vice Chairman and President | Current |
| BELLUS Health Inc. | Consultant | Current |
| RAE Systems Inc. | Member, Chair | Current |
| Equity One, Inc. | Board of Directors | Current |
| Continucare Corporation | Director | Current |
| Chipotle Mexican Grill, Inc. | Director | Current |
| BELLUS Health Inc. | Director | Current |
| IVAX Corporation | Vice Chairman | Current |
| Harvard College | A.B | Former |
| Heller Ehrman LLP | Life Sciences Legal Practice Group Team | Former |
| Syntex Corporation | Former | |
| Israelamericafoundation.Com | Chairman | Former |
| RAE Systems Inc. | Board of Directors | Former |
| Harvard Law School | J.D. | Former |
| Harvard College | A.B. | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | CIO & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Chief Scientific Officer | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | CFO & Senior Vice President, Finance | Current |
| IVAX Diagnostics, Inc. | Cfo | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Chief Accounting Officer | Current |
| IVAX Diagnostics, Inc. | Vice President, Finance | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Senior Vice President | Current |
| Bioxelpharma Inc. | Board of Directors | Current |
| Ontario College of Pharmacists | Board of Directors | Current |
| Geopharma, Inc. | Director | Current |
| Dex-C20 | Director | Current |
| Ontario College of Pharmacists | Member | Current |
| IVAX Pharmaceuticals Inc. | President & CEO | Former |
| Novopharm Limited | Chief Operating Officer | Former |
| Novopharm Limited | Executive Vice President | Former |
| McGill University | Diploma In Management | Former |
| McGill University | MBA | Former |
| McGill University | Diploma In Management | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | General Counsel, Senior Vice President & Secretary | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Diagnostics, Inc. | Vice President, HR | Current |
| IVAX Corporation | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, Strategic Planning | Current |
| IVAX Diagnostics, Inc. | Vice President, Strategic Planning | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, Latin America | Current |
| IVAX Diagnostics, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Diagnostics, Inc. | Vice President | Current |
| IVAX Corporation | Vice President, Taxation & Tax Counsel | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Director, Investor Relations & Corp Communications | Current |
| IVAX Corporation | Director, Investor Relations & Corp Communications | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Director, Operations, Latin America | Current |
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
